PE20060619A1 - Derivados de oxazolidinona como antibacterianos - Google Patents
Derivados de oxazolidinona como antibacterianosInfo
- Publication number
- PE20060619A1 PE20060619A1 PE2005000792A PE2005000792A PE20060619A1 PE 20060619 A1 PE20060619 A1 PE 20060619A1 PE 2005000792 A PE2005000792 A PE 2005000792A PE 2005000792 A PE2005000792 A PE 2005000792A PE 20060619 A1 PE20060619 A1 PE 20060619A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- thioamide
- oxazolidinyl
- furan
- oxo
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- -1 OXAZOLIDINONE COMPOUND Chemical class 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
REFERIDA A UN COMPUESTO DE OXAZOLIDINONA DE FORMULA I, DONDE R1, R2, R3 Y R4 SON H, F Y Cl; A ES UN RADICAL SELECCIONADO DE (i), (ii), (iii) Y (iv); R5 Y R6 SON H, F, Br, CN, ENTRE OTROS; R7 ES H, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; R8 Y R9 SON H, CN, CLQUILO C1-C6, ENTRE OTROS; R10 ES H, ALQUILO C1-C6, COR13, ENTRE OTROS; n ES 0 O 1; R13 ES H, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-[[(5S)-3-[3-FLUORO-4-MORFOLIN-4-IL-FENIL]-2-OXO-5-OXAZOLIDINIL]METIL]FURAN-3-IL-TIOAMIDA, N-[[(5S)-3-[3-FLUORO-4-(4'-TIOACETIL-4-PIPERAZINIL)-FENIL]-2-OXO-5-OXAZOLIDINIL]METIL]FURAN-3-IL-TIOAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON ACTIVOS CONTRA BACTERIAS GRAMPOSITIVAS Y GRAMNEGATIVAS, CON UNA DEBIL ACTIVIDAD INHIBITORIA DE LA MONOAMINOOXIDASA (MAO) Y SON UTILES PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04103657 | 2004-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060619A1 true PE20060619A1 (es) | 2006-07-11 |
Family
ID=35355681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000792A PE20060619A1 (es) | 2004-07-29 | 2005-07-07 | Derivados de oxazolidinona como antibacterianos |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20090005369A1 (es) |
| EP (1) | EP1786805A1 (es) |
| JP (1) | JP2008508236A (es) |
| KR (1) | KR20070048227A (es) |
| CN (1) | CN101027296A (es) |
| AR (1) | AR050426A1 (es) |
| AU (1) | AU2005266318A1 (es) |
| BR (1) | BRPI0512691A (es) |
| CA (1) | CA2574668A1 (es) |
| MX (1) | MX2007001065A (es) |
| NO (1) | NO20070870L (es) |
| PA (1) | PA8640401A1 (es) |
| PE (1) | PE20060619A1 (es) |
| RU (1) | RU2007107490A (es) |
| TW (1) | TW200612923A (es) |
| UY (1) | UY29012A1 (es) |
| WO (1) | WO2006010756A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006033572A1 (de) * | 2006-07-20 | 2008-01-24 | Bayer Cropscience Ag | N'-Cyano-N-halogenalkyl-imidamid Derivate |
| EP2072513A1 (en) | 2007-12-17 | 2009-06-24 | Ferrer Internacional, S.A. | A cyano piperidinyl-phenil-oxazolidinone and use thereof |
| EP2655362A1 (en) | 2010-12-22 | 2013-10-30 | Abbvie Inc. | Hepatitis c inhibitors and uses thereof |
| CN103420996B (zh) * | 2013-09-07 | 2015-06-24 | 吉首大学 | 苯并吡喃酮-胺甲基-噁唑烷酮类化合物及其制法和用途 |
| CN103420995B (zh) * | 2013-09-07 | 2015-07-01 | 吉首大学 | 噁唑烷酮-烷胺基-呋喃酮型化合物及其制法和用途 |
| CN103483329B (zh) * | 2013-09-07 | 2015-08-05 | 吉首大学 | 呋喃酮-芳基-噁唑烷酮型化合物及其制法和用途 |
| US12109203B2 (en) * | 2018-07-25 | 2024-10-08 | Zydus Lifesciences Limited | Substituted oxazolidinones for the treatment of mammalian infections |
| WO2021184339A1 (en) | 2020-03-20 | 2021-09-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1250538A (es) * | 1969-03-18 | 1971-10-20 | ||
| DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE10105989A1 (de) * | 2001-02-09 | 2002-08-14 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| WO2003048136A1 (en) | 2001-11-29 | 2003-06-12 | Merck & Co., Inc. | Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof |
| TW200302095A (en) | 2002-01-25 | 2003-08-01 | Upjohn Co | Oxazolidinone cotherapy |
| IL164195A0 (en) * | 2002-03-29 | 2005-12-18 | Upjohn Co | Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
| AU2003215861A1 (en) * | 2003-04-07 | 2004-11-01 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
-
2005
- 2005-07-07 TW TW094122949A patent/TW200612923A/zh unknown
- 2005-07-07 PE PE2005000792A patent/PE20060619A1/es not_active Application Discontinuation
- 2005-07-11 AR ARP050102865A patent/AR050426A1/es not_active Application Discontinuation
- 2005-07-12 UY UY29012A patent/UY29012A1/es unknown
- 2005-07-26 JP JP2007523076A patent/JP2008508236A/ja active Pending
- 2005-07-26 BR BRPI0512691-6A patent/BRPI0512691A/pt not_active IP Right Cessation
- 2005-07-26 WO PCT/EP2005/053627 patent/WO2006010756A1/en not_active Ceased
- 2005-07-26 KR KR1020077005026A patent/KR20070048227A/ko not_active Withdrawn
- 2005-07-26 AU AU2005266318A patent/AU2005266318A1/en not_active Abandoned
- 2005-07-26 MX MX2007001065A patent/MX2007001065A/es not_active Application Discontinuation
- 2005-07-26 CN CNA2005800320206A patent/CN101027296A/zh active Pending
- 2005-07-26 EP EP05762921A patent/EP1786805A1/en not_active Withdrawn
- 2005-07-26 CA CA002574668A patent/CA2574668A1/en not_active Abandoned
- 2005-07-26 RU RU2007107490/04A patent/RU2007107490A/ru not_active Application Discontinuation
- 2005-07-26 PA PA20058640401A patent/PA8640401A1/es unknown
- 2005-07-26 US US11/658,670 patent/US20090005369A1/en not_active Abandoned
-
2007
- 2007-02-15 NO NO20070870A patent/NO20070870L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2007107490A (ru) | 2008-09-10 |
| JP2008508236A (ja) | 2008-03-21 |
| EP1786805A1 (en) | 2007-05-23 |
| PA8640401A1 (es) | 2006-03-24 |
| UY29012A1 (es) | 2005-10-31 |
| MX2007001065A (es) | 2007-04-10 |
| WO2006010756A1 (en) | 2006-02-02 |
| KR20070048227A (ko) | 2007-05-08 |
| TW200612923A (en) | 2006-05-01 |
| AR050426A1 (es) | 2006-10-25 |
| CN101027296A (zh) | 2007-08-29 |
| AU2005266318A1 (en) | 2006-02-02 |
| BRPI0512691A (pt) | 2008-04-01 |
| CA2574668A1 (en) | 2006-02-02 |
| NO20070870L (no) | 2007-04-16 |
| US20090005369A1 (en) | 2009-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2004000400A1 (es) | Compuestos derivados de piridina sustituida con 1,3-oxazol y con isoxazol, composicion farmaceutica, procedimiento de preparacion, utiles como agentes antibacteriano, activo contra la bacteria gram negativa. | |
| PE20130385A1 (es) | Derivados del acido naft-2-ilacetico para tratar el sida | |
| PE20201256A1 (es) | Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas | |
| EA200501820A1 (ru) | Терапевтические средства для лечения боли | |
| AR038576A1 (es) | Formulaciones de drogas antibioticas oftalmicas que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio | |
| MX2009012390A (es) | Uso de compuestos de 4-(pirrolidin-1-il)quinolina para exterminar microorganismos clinicamente latentes. | |
| PE20090601A1 (es) | Derivados de piridin-il-oxi-piridinas como inhibidores de alk5 | |
| PE20061124A1 (es) | Compuestos y derivados de dibencil amina | |
| PE20110150A1 (es) | Amidofenoxiindazoles como inhibidores de c-met | |
| BR122012009489B8 (pt) | processo para produzir 2-etóxi-1-{[2-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso | |
| PE20091065A1 (es) | Derivados bis-(sulfonilamino) en terapia 066 | |
| PE20090649A1 (es) | DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1 | |
| IN2012DN01325A (es) | ||
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal | |
| EA200970535A1 (ru) | Антибактериальные производные хинолина | |
| PE20110069A1 (es) | Compuestos de tetraciclina sustituidos | |
| NZ504503A (en) | Oxazolidinone derivatives and pharmaceutical use as antimicrobial agents | |
| PE20100053A1 (es) | Compuestos heterociclicos como inhibidores de la adn girasa | |
| NZ594675A (en) | Actagardine derivatives | |
| CA2744756A1 (en) | Monocarbams and their use as antibacterial agent | |
| PE20051054A1 (es) | Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento | |
| PE20091959A1 (es) | Derivados de urea heterociclicos como antibacterianos | |
| BRPI0411688A (pt) | antibióticos de oxazolidinona substituìda de grupo de ciclopropil e seus derivados | |
| PE20080283A1 (es) | Profarmacos antimicrobianos de oxazolidinona | |
| PE20061490A1 (es) | Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |